495 related articles for article (PubMed ID: 27018306)
1. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
2. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer.
Chen X; Liu M; Meng F; Sun B; Jin X; Jia C
J Cell Biochem; 2019 Jan; 120(1):243-252. PubMed ID: 30216500
[TBL] [Abstract][Full Text] [Related]
3. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
[TBL] [Abstract][Full Text] [Related]
4. Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.
Zhuang C; Li J; Liu Y; Chen M; Yuan J; Fu X; Zhan Y; Liu L; Lin J; Zhou Q; Xu W; Zhao G; Cai Z; Huang W
Oncotarget; 2015 Dec; 6(38):41194-203. PubMed ID: 26517688
[TBL] [Abstract][Full Text] [Related]
5. shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells.
Li J; Zhuang C; Liu Y; Chen M; Zhou Q; Chen Z; He A; Zhao G; Guo Y; Wu H; Cai Z; Huang W
Oncotarget; 2016 May; 7(20):28989-97. PubMed ID: 27015551
[TBL] [Abstract][Full Text] [Related]
6. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
[TBL] [Abstract][Full Text] [Related]
7. [Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells
Deng R; Zhang F; Lei F; Liu W; Liu S; Wang W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1615-1621. PubMed ID: 33243752
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
Lin J; Liu Y; Zhan Y; Zhuang C; Liu L; Fu X; Xu W; Li J; Chen M; Cai Z; Huang W
Tumour Biol; 2016 Mar; 37(3):3115-21. PubMed ID: 26427661
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
10. Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells.
Chen Y; Xie H; Zou Y; Lai X; Ma L; Liu Y; Li J
Mol Biosyst; 2017 Jul; 13(8):1597-1607. PubMed ID: 28671703
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma.
Lin H; Zhao Z; Hao Y; He J; He J
Biochem Cell Biol; 2020 Apr; 98(2):284-292. PubMed ID: 31626739
[TBL] [Abstract][Full Text] [Related]
12. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
Chen M; Li J; Zhuang C; Cai Z
Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.
Rui X; Wang L; Pan H; Gu T; Shao S; Leng J
J Cell Mol Med; 2019 Feb; 23(2):865-876. PubMed ID: 30394665
[TBL] [Abstract][Full Text] [Related]
14. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer.
Liu L; Liu Y; Zhuang C; Xu W; Fu X; Lv Z; Wu H; Mou L; Zhao G; Cai Z; Huang W
Tumour Biol; 2015 Sep; 36(10):7685-9. PubMed ID: 25934337
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.
Zhang J; Shi Z; Nan Y; Li M
Int Urol Nephrol; 2016 May; 48(5):711-6. PubMed ID: 26861061
[TBL] [Abstract][Full Text] [Related]
16. HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer.
Wang Y; Zhang G; Han J
J Cell Biochem; 2019 Jun; 120(6):10513-10518. PubMed ID: 30635931
[TBL] [Abstract][Full Text] [Related]
17. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.
Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L
Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291
[TBL] [Abstract][Full Text] [Related]
19. lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia.
Li L; Wang M; Mei Z; Cao W; Yang Y; Wang Y; Wen A
Biomed Pharmacother; 2017 Dec; 96():165-172. PubMed ID: 28985553
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA GHET1 promotes the development of bladder cancer.
Li LJ; Zhu JL; Bao WS; Chen DK; Huang WW; Weng ZL
Int J Clin Exp Pathol; 2014; 7(10):7196-205. PubMed ID: 25400817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]